Our data demonstrated that OD in siGSN#1 treated cells was significantly lower compared with siRNA-treated control cells (p < 0.001), indicating that depletion of GSN is accompanied by a reduction in the proliferation potential of bladder cancer cells. This evidence concerns the gene GSN and urinary bladder carcinoma.